Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

AMETHYST – Lupus Study

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

elderly man's hands


AGE: 18+ years old
TYPE: Experimental Treatment Study
CONDITION: Cutaneous Lupus Erythematosus (CLE)

Learn More About This Research Study

For more information, please contact study coordinator, Kymberlyn Warner King at 216-844-7546 or complete the form below.

Study Purpose

The purpose of this study is to evaluate if the investigational study drug, BIIB059, can reduce disease activity and inflammation in people with active CLE compared to a placebo.

Who Can Participate

Participants 18 years and older who has been diagnosed with an autoimmune disease known as cutaneous lupus erythematosus may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot